Buscar
Mostrando ítems 11-20 de 100
Imatinib derivatives as inhibitors of K562 cells in chronic myeloid leukemia
(Springer Verlag (Germany), 2018)
Hyaluronan oligomers sensitize chronic myeloid leukemia cell lines to the effect of imatinib
(Oxford University Press, 2016-04)
Chronic myeloid leukemia is a myeloproliferative syndrome characterized by the presence of the Philadelphia chromosome (Ph), generated by a reciprocal translocation occurring between chromosomes 9 and 22 [t(9;22)(q34;q11)]. ...
Leucemia Mielóide Crônica: novas drogas em desenvolvimentoChronic Myeloid Leukemia: development of new drugs
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2008)
Follow-up of the tumor load in patients with de novo chronic myeloid leukemia and in complete cytogenetic remission treated with imatinib in Colombia.
(2013-07-08)
Objective: To evaluate the hematological, cytogenetic, and molecular
responses in Colombian patients with CML chronic
myeloid leukemia (CML) treated with imatinib.
Methods: Two groups of patients, one with the novo ...
Perfil global de expressão de micro-RNAS circulantes como marcadores de resposta terapêutica na leucemia mielóide crônica
(Universidade Estadual Paulista (UNESP), 2016)